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Pharmacy

Effects of McN.2165 on Isolated Guinea Pig Atria
Director: Charles L. Eyer, Ph.D.
Spontaneously beating right and electrically driven left guinea pig
atria were used to evaluate the in vitro effects of McN.2165, a proven
arrhythmogenic
agent
in vivo.
This
compound
produced
negative
chronotropic and ^inotropic effects
right atrial preparations
(3x10 mM, 4.5x10 mM, 7.5x10 mM, 1x10 mM) . Negative inotropism was
also observed for left atria. At these concentrations of McN.2l65, the
threshold of the left atria was increased significantly (p < 0.05).
Prolongation of the maximal following frequency was noted only at the
higher McN.2165 concentration (1x10 mM).
Interactions of McN.2165 and calcium ions on the cardiac parameters
were assessed at various calcium concentrations (2.7mM, 2.0mM, l.OmM,
and
0.7mM).
High
and
low calcium concentrations
(2.7mM,
ImM,
respectively) surmountably antagonized the cardiodepressant effects of
McN.2165 on right atria. In left atrial preparations calcium inhibited
the McN.2165-induced increase in threshold and prolongation of maximal
following frequency.
Both the positive inotropic and positive chronotropic effects
elicited
by
isoproterenol
in
right
atrial
preparations
were
insurmountably antagonized by McN.2165.
Isoproterenol alone had no
effect on the electrical threshold of left atria, but did shorten the
maximal following frequency. Whereas the latter effect of isoproterenol
was not modified by McN.2165, it did produce its typical increase in
cardiac threshold in presence of beta agonist.
McN.2165 demonstrated antiarrhythmic effects in vitro in contrast to
the situations in vivo. Although a definite mechanism of action could
not be deduced, the antiarrhythmic action does involve a calcium
dependent process.
Beta^ adrenoceptor blockade is not contributory to
the antiarrhythmic actions of McN.2165.
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Introduction
The heart is a hollow, muscular organ situated in the thorax behind the
sternum and between the lungs.

The heart pumps blood throughout the

body delivering nutrients to and removing wastes from the organs.

Also,

it provides for the transport of hormones and other regulatory
substances between various regions of the body.

A normal functioning

heart requires a normal excitation contraction mechanism.

The

excitatory impulse that activates the myocardium is neither initiated by
nor conducted through nervous tissue.

Excitation results from the flow

of depolarizing current across the cell membrane.

If the current is of

sufficient magnitude to depolarize the membrane to a critical level, the
threshold potential, the response can initiate an action potential (AP).
In certain fibers the depolarizing currents arise spontaneously,
Automaticity can be defined as the ability of certain fibers, designated
as automatic cells, to undergo self-excitation and initiate impulses
spontaneously.

The conducting system of the heart is composed of muscle

fibers specially differentiated for the task of initiating the sequence
of events in the cardiac cycle, of controlling its regularity, and of
transmitting the impulses from the atria to the ventricles.

Such a

coordinated normal sequence of excitation allows the heart to contract
in a coordinated fashion-

This, in turn, permits the heart to pump

blood efficiently.
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Activation of the heart normally begins in the sinoatrial (SA)
node, which lies in the sulcus between the superior vena cava and the
right atrium.

This region is commonly referred to as the pacemaker, for

it normally initiates the wave of depolarization that is propagated
through the myocardium to excite the rest of the heart.

Because of

proximity of the SA node to the atria, the first structures in the
normal activation sequence of the heart are the atria.

The AV

(atrioventricular) node is located at a critical point controlling the
only normal conduction path between the atria and ventricles.

There is

a short delay of approximately 0.04 sec. due to the slow passage of the
wave of depolarization from the atria to the ventricles by way of the AV
node.

There are two advantages of this normal delay: (1) postponement

of ventricular excitation until the atria have had time to eject their
contents into the ventricles, and (2) limitation in the maximum number
of signals which can be accommodated for transmission by the AV node.
The wave of electrical depolarization reaches the ventricles via the
bundle of His and its divisions, the right and left bundle branches.
These structures then ramify, giving rise to an endocardial network of
Purkinje fibers-

These fibers are specialized conduction tissue that

carry the impulses to all parts of the ventricular myocardium.
Specialized cells in the normal heart possess the property of
automaticity.

Under circumstances where the normal pacemaker cells are

suppressed, the subsidiary pacemaker cells serve the function of
maintaining the heart beat.

Automaticity of subsidiary pacemakers can

occur as a result of many factors such as myocardial cell damage due to
infarction, digitalis toxicity, or excessive amounts of catecholamines.

R eproduced with permission of the copyright owner. Further reproduction prohibited without permission.

3

As a result, the enhancement of automaticity in specialized cardiac
cells can lead to an ectopic focus which may cause cardiac arrhythmias.
The normal heart rhythm is dominated by the automaticity of the SA node.
The subsidiary pacemakers discharge at a slower rate than those of the
SA node, and their rate of discharge is not as well modulated by the
autonomic nervous system (Katz, 1977).
The heart is innervated by both sympathetic and parasympathetic
fibers.

The former arise from the forth and fifth segments of the

thoracic spinal cord and reach the heart by way of synaptic connections
in the cervical and thoracic regions of the heart.

The sympathetic

nerve fibers release the catecholamine, norepinephrine-

On the basis of

qualitative organ responses to various catecholamines, Ahlquist (1948)
concluded that two distinct receptors, alpha and beta, exist.
Activation of alpha receptors leads to vasoconstriction, contraction of
the uterus and many other distinctive effects.

On the other hand,

activation of beta receptors causes vasodilation, cardiac stimulation,
uterine inhibition and other effects.

Lands and coworkers (1967)

subdivided beta receptors into two subgroups.
found in the heart.

Most beta^ receptors are

Their stimulation leads to increase in the rate of

spontaneous diastolic depolarization in the SA nodal cells.
increases heart rate.

This

Also beta^ receptors can increase the force of

contraction of the heart.

Beta^

receptors are present mostly in the

vascular beds and bronchi, their activation leads to vaso - and
bronchodilation.
Catecholamines exert their beta actions via the cyclic nucleotide
system (Malkinson, 1975).

Beta receptor activation elevates intracell-

R eproduced with permission of the copyright owner. Further reproduction prohibited without permission.

4

ular concentrations of cyclic 3', 5 ’ adenosine monophophate (cAMP),
triggering subsequent biochemical reactions leading to organ response.
The parasympathetic innervation of the heart originates in the
medulla oblongata, where parasympathetic fibers arising in the vagal
nuclei reach the heart by the cardiac branches of the vagus nerve.

The

parasympathetic nerves release the chemical neurotransmitter
acetylcholine, which causes a decrease in the rate of pacemaker
discharge and a slowing of the heart rate.

The parasympathetic

innervation of the heart supplies mainly the SA and AV nodes and the
atria, while sympathetic fibers are distributed to all regions of the
heart.

Alterations in automaticity by acetylcholine and the

catecholamines represent important mechanisms whereby heart rate is
adapted to meet changing needs.

They also represent an important cause

of arrhythmias (Somani and Lum, 1966).
A voltage difference exists across the surface membrane of all
cardiac cells.

This is called the resting membrane potential.

For most

cardiac cells, the resting transmembrane potential difference is about
-80 to -90 mV relative to the extracellular fluid.

An impulse can be

generated by an excitable membrane when its transmembrane potential is
reduced (becomes less negative) from the normal resting potential to the
threshold potential.

The cardiac action potential (AP) occurs when

cardiac cells are excited above the threshold potential.

The nature of

cardiac AP varies depending on the area of the heart from which it is
recorded.

The ionic permeabilities during diastole in cell membranes of

the SA pacemaker cells, are not constant (Beeler and Reuter, 1970b).
Such ionic changes cause membrane potential to decrease spontaneously
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until threshold is reached and an AP is initiated.
4 depolarization or pacemaker potential.

This is called phase

The atrial AP is similar to

the typical AP of Purkinje fibers, but shorter in duration. Diastolic
potential (phase 4) is constant, i.e., pacemaker activity is absent.
The AP duration in the AV node is longer than in the atrium, but less
than in Purkinje fibers (Katz, 1977).
that of Purkinje fibers.

The ventricular AP is similar to

Nevertheless, spontaneous diastolic (phase 4)

depolarization is not seen under normal conditions, i.e., lack of
pacemaker activity.

The ventricular AP duration is longer than that of

the atria and shorter than that of His-Purkinje system.

The AP duration

in the more distal regions of Purkinje fibers are the longest found in
the mammalian heart (McAllister, 1975).
The AP of Purkinje fiber, in which the ionic basis for the
electrical events during depolarization has been studied most
extensively, is divided into five well defined phases (McAllister ^
al., 1975).

These phases are also found in other APs of some areas of

the heart.
Phase zero is a rapid depolarization.

The interior of the cell

membrane becomes positively charged relative to the extracellular
medium.

This rapid upstroke of the AP is due to a sudden increase in

the sodium conductance.

Sodium ions will enter the cell (down their

concentration gradient) through special sodium channels, whose opening
and closing can be regarded as resembling the opening and closing of a
gate.

The intense inward sodium current carries sufficient positive

charge into the cell to move the transmembrane voltage to a value near
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the sodium equilibrium potential.

At the same time the membrane is

relatively impermeable to potassium.
Phase one is a brief period of rapid repolarization brought about
by inactivation of sodium current, and possible activation of an inward
chloride current (McAllister et

, 1975; Nosek, 1979).

Phase two, the plateau phase, is responsible for the prolonged
cardiac AP.

Primarily it is due to a slow inward current carried by

calcium ions(i

) (Beeler and Reuter, 1970a). Calcium ions enter the
®i
myocardium during the late part of the upstroke and during the plateau
phase of the cardiac AP (Beeler and Reuter, 1970b; Reuter, 1967).
concentration of extracellular calcium,

[Ca]

+2

o

The

, determines the force of

contraction of isolated cardiac muscle of man, rabbit and other species
(Toda, 1969; Landmark and Refsum, 1975).

In the presence of high

[Ca]^^, it is conceivable that intracellular Ca^^ concentration,

(Ca)T^,

will also increase.

It has been shown that calcium ions can activate

potassium currents.

In most cases, only one of several available

voltage-dependent membrane potassium currents is activated by calcium
and abolished upon the removal of external calcium (Gorman and Thomas,
1980).

In cardiac Purkinje fibers, the injection of calcium ions

increased both i

and i

Kg (background outward current and diastolic

outward current respectively)

(McDonald, 1982).

Phase three involves repolarization of the cardiac muscle.

When

the slow channel is inactivated, i
decreases and the cell tends to
®i
repolarize. Repolarization is aided by the time dependent activation of
an outward current, i
(Braunwald, 1980). Experimental results
*1
indicates that activation of i
is required for AP repolarization,
^1
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i.e., inactivation of i

alone is usually insufficient to cause

repolarization in the absence of i

, (Kass et _al., 1976b).

Most of

""l

+

the charge flowing through the i
channel is probably due to K
*1
(Gorman, 1980).
Phase four is the resting membrane potential.

The inside of the

cell is negatively charged with respect to the outside due to the
ability of the cell to maintain sodium and potassium gradients (Katz,
1977).
Cardiac arrhythmias are abnormal rhythm formations due to either
altered impulse formation (automaticity), altered conduction, or a
mixture of both.

Conduction velocity is a function of the amplitude of

the AP and its rate of rise (dV/dt)

(Singer et al., 1967).

Both of

these variables are predictably related to the membrane potential at the
onset of the AP (Weidmann, 1955).

A smaller (less negative) membrane

potential results in a decrease in the amplitude of the AP, and
decreased conduction velocity.

Slowed conduction velocity may be a

critical factor in the genesis of some cardiac arrhythmias.

Décrémentai

conduction is a phenomenon which occurs when a normal AP enters a region
of the myocardium in which conduction velocity becomes slowed.

It is

seen when an impulse is propagated in a region of the myocardium in
which the opening of the fast sodium channels is impaired, causing the
amplitude and rate of rise of the AP to be decreased.

The physiological

slowing of impulse propagation, especially through the AV node may lead
to a partial or a complete block type of cardiac arrhythmia.
Premature contractions, also called extrasystoles, premature beats,
or ectopic contractions, are contractions of the heart prior to the time
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that normal contraction would have been expected.

The extrasystoles

originate in ectopic foci in the atria, the ventricles, or the AV
junctional tissue and may initiate episodes of sustained tachyarrhyth
mias of either supraventricular or ventricular origin.

Some of these

ectopic rhythms are due to altered automaticity in the specialized
fibers.
Ectopic rhythms may result from mechanisms other than enhanced
automaticity of the specialized fibers.

These abnormal mechanisms are

related to the phenomenon called reentry (Allessie et aj^., 1973;
Antzelevitch et al., 1980).

Reentry or continuous conduction is

dependent on the direction and velocity of propagation of the cardiac
impulse and on refractoriness in the circuit (Schmitt, 1929; Goldreyer
and Bigger, 1971).

In normal propagation, conduction proceeds with

equal velocity through both limbs of a terminal Purkinje fiber bundle
and then activates the myocardium.

If a diseased area is present,

including partially depolarized Purkinje fibers, antegrade activation
through the site is blocked (unidirectional block).

Activation proceeds

normally through the other limb to the myocardium and then activates the
depressed segment in a retrograde direction.

This impulse propagates

slowly through the depressed segment and reenters the proximal
conducting system (Rosen et ajL., 1975).

To initiate reentry,

unidirectional block must be present at some point in the circuit, and,
to maintain continuous conduction, the circuit length must exceed the
wavelength of the reentrant impulse.

The wavelength of the impulse is

the product of the mean conduction velocity and the duration of the
longest refractory period in the circuit.

If reentry is to occur,
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either the conduction velocity or the duration of refractoriness must be
reduced.

Wit and coworkers (1972) have shown that a local area of slow

conduction in a Purkinje network with ringlike geometry can produce
continuous conduction.

Reentry can occur in many sites in the heart,

such as the SA node (premature atrial depolarization), the atria (atrial
flutter or fibrillation), the AV node (paroxysmal supraventricular
tachycardia), and the ventricles (ventricular premature depolarization,
ventricular tachycardia).

Recently Cranefield and coworkers (1971) have

studied conduction disturbances caused by the application of KCl to
small, localized zones of Purkinje fibers.
extracellular K

Clinically the increase in

can occur as a result of myocardial cell damage and

ischemia (Katz, 1977).

A large increase in

results in elevation of

the threshold and depression in the upstroke velocity.

Depolarization,

elevation of threshold, and slowing of upstroke velocity, all lead to a
reduction of conduction velocity.

Elevation of extracellular

increases membrane permeability and diminishes the electrotonic spread
of the AP which in turn further depresses conduction velocity.
The ideal approach to the treatment of cardiac arrhythmias depends
on a proper identification of the arrhythmia, an understanding of the
factors involved in their production, and the understanding of the
clinical effects of the antiarrhythmic agents.

The antiarrhythmic drugs

were classified into four different classes according to their mode of
action (Vaughan Williams, 1980).

Class 1 antiarrhythmic drugs are

represented by quinidine and other similarly acting compounds. This
class restricts the fast inward depolarizing current carried by sodium
ions.

As a result, the maximum rate of depolarization (MRD) is very
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much reduced and the amplitude of the upstroke of the AP is lowered.
This will decrease the conduction velocity.

Quinidine reduces the rate

of rise of AP much more at higher than at low frequencies of
stimulation.

It is thus antifibrillatory because it cuts out the

propagation of abnormal high frequency impulses without any effect on
lower frequency rhythm (Vaughan Williams, 1958; Szekeres and Vaughan
Williams, 1962).

Similar compounds with class 1 antiarrhythmic actions

include procainamide, lidocaine, and diphenylhydantoin (DPH).
lidocaine have different mechanism of action.

DPH and

Bigger and coworkers

(1968) found that DPH in therapeutic concentration did not decrease
membrane responsiveness or conduction velocity.

On the contrary, it

actually increased these two parameters in addition to abbreviation of
both AP duration and effective refractory period (ERP) especially in
depressed cardiac cells.

The efficacy of DPH in abolishing cardiac

arrhythmias was attributed to improvement of conduction in the reentrant
pathway (Dreifus et

, 1970, Rosen and Hoffman, 1973).

Other

investigators have found that DPH effects are similar to those of
quinidine in producing marked retardation of conduction velocity and
depression of membrane responsiveness, especially in the presence of
high extracellular K
Hauswirth, 1974).

(Nabil El-Sherif and Lazzara, 1978; Singh and

In vivo experiments showed that lidocaine depressed

conduction much more in the ischemic myocardium than in normal cardiac
tissue (Kupersmith et al., 1975).

Because of this selective depressant

effect on ischemic tissue, lidocaine could convert areas of
unidirectional block and slow conduction into areas of total block,
abolishing a potential reentry mechanism (Sasyniuk and Mattel, 1982).

R eproduced with permission of the copyright owner. Further reproduction prohibited without permission.

11

On the other hand, lidocaine abbreviates the refractory period (RP) of
normal tissue.

Therefore it could slow conduction through infarcted

tissue just enough to allow re-excitation of surrounding normal tissue,
in which the RP has been abbreviated by the drug. Compounds of this
class also behave as local anesthetics or membrane stabilizers.
However, the concentration of the antiarrhythmic drugs required to
depress the excitability of the heart is much lower than that required
for the local anesthetic effect (Goodman and Gilman, 1980).
Class 2 antiarrhythmic agents have antisympathetic actions, either
by beta receptor blockade (propranolol) or by interference with the
release of the sympathetic transmitter (bretylium).

The antiarrhythmic

action of beta blockers was first shown with dichloroisoproterenol (DCI)
in 1959 (Swain, 1959).

It was established later (Lucchesi and Hoffman,

1961) that the antiarrhythmic effect was due to two different
mechanisms, a beta blocking effect and a membrane stabilizing effect
(quinidine-like effect).

Propranolol, a non-specific beta antagonist,

is considered as the prototype of this class.
upstroke velocity and magnitude of the AP.

Propranolol reduces the

The beta blocking action may

be shown quantitatively by reversal of isoproterenol-induced tachycardia
and increased force of myocardial contraction or reversal of peripheral
vasodilation (Ahlquist, 1968).
the atria and the AV node.
of beta blockade.

Propranolol prolongs the conduction in

These effects can be explained on the basis

Experimentally, propranolol has been shown to reduce

the duration of AP in both atrial muscle and Purkinje fibers (Goodman
and Gilman, 1980; Davis and Temte, 1969) by increasing the outward
background current (i. ).
^1

This will shorten the early phases of
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repolarization-

Beta blockers are successfully used in sinus

tachycardia, in supraventricular tachycardia and arrhythmias
precipitated by exercise or emotion, in Wolf-Parkinson-White syndrome
(WPWS) (Wu ^t ad., 1974), in ventricular tachycardias, and in
suppressing ectopic beats due to digitalis intoxication (Gillis, 1969).
Class 3 antiarrhythmic drugs act by prolonging the cardiac AP
duration.

Accelerated repolarization shortens the RP and, if

sufficiently marked as with acetylcholine

in atrial muscle, may result

in development of cardiac arrhythmias (Gillis, 1976).
repolarization might, therefore, be antiarrhythmic.

Delay in
Amiodarone, a

benzofuran derivative, was introduced 20 years ago as an antianginal
drug (Singh and Vaughan Williams, 1970).

In hyperthyroidism atrial

fibrillation is common, whereas in hypothyroidism, cardiac arrhythmias
are rare.

Thyroidectomy causes a large and uniform prolongation of

action potential duration (APD) (Freedberg, ^

alL., 1970).

Although not

an antithyroid drug, amiodarone was found to mimic hypothyroid state by
prolonging APD in both atria and ventricles (Singh and Vaughan Williams,
1970).

This proved to be the case both in animals and in man.

The

antiarrhythmic effects of amiodarone may be attributed to two distinct
properties —

an acute effect, due to its antisympathetic action (class

2), and a delayed effect, due to prolongation of APD (class 3).
Class 4 agents are slow inward calcium channel blocking agents.
Calcium ions are major ions involved in cardiac excitation-contraction
coupling mechanism (Fabiato, 1979).

In recent years the slow response

has received considerable attention because of the ease with which it
produces reentrant arrhythmias.

Also, conditions promoting i
and slow
s.
1
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response, i.e., depolarized tissues and excess catecholamines, play a
role in the development of human cardiac arrhythmias.

In working heart

muscle the slow inward Ca current is suppressed by a variety of blocking
agents (Kass and Tsien, 1975; Ehara and Daufmann, 1978).

The organic

compounds verapamil and its methoxy derivative D600 are examples.
Verapamil, decreases depolarization in sinus and AV nodal cells (Brown
and Difrancisco, 1980).

It also depressed normal automaticity in canine

Purkinje fibers (Cranefield £t ajL., 1974) .
have other effects as well.
carried mostly by K
+2

[Ca3^ , increases K

+

They act on i

(McDonald, 1982).

The calcium channel blockers
, the fast outward current

High extracellular calcium,

uptake by increasing the potassium conduction as
+2

suggested by the fact that high [Ca]^

shortens the AP and increases

maximum diastolic potential in Purkinje fibers (McGuigan, 1976).
result, [Ca]

+2

o

can increase K

+

movement.

repolarization by increasing i

As a

This will accelerate

and by shifting the plateau to more

positive values (Kass and Tsien, 1975; 1976a).

This increase in the

time-dependent outward plateau current may be due to changes in membrane
surface charges (Shea,1971).
Screening for antiarrhythmic drugs can be accomplished by a series
of in vitro measurements.
A.

Electrical threshold —

Increasing (more negative) electrical

threshold is antiarrhythmic action.

A stronger stimulus is required to

elicit a propagated AP.
B.

Maximum following frequency is an estimation of the RP.

Shortening of the AP duration (APD), which is usually accompanied by a
shortening in the RP, is an arrhythmogenic action (Goodman and Gilman,
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1980).
effect.

Prolongation of such parameter is considered as antiarrhythmic
On the other hand, increasing the APD above a certain magnitude

may in fact initiate an ectopic focus leading eventually to arrhythmias
(Singer and Ten Eick, 1969).
C.

Peak developed tension is an estimation of the force of

contraction (inotropic effect).

Negative inotropism is a property of

many antiarrhythmic agents (Graca and Zwieten, 1971).
D.

Spontaneous frequency (chronotropic effect) is a measure of the

normal automaticity of the SA node.

Depression of abnormal automaticity

is a good approach for the control of some types of arrhythmias (Singer
and Ten Eick, 1969).
Measurements of these parameters (threshold, maximum following
frequency, peak developed tension and spontaneous frequency) will not
only detect antiarrhythmic actions, but can give insight into the
mechanism of action of a particular drug.

For example, class 1 action

will reduce the maximum following frequency and raise the electrical
threshold (Salako e_t

, 1976) .

Reversal of the positive ino- and

chronotropism of isoproterenol, a powerful beta agonist, is an
indication of class 2 beta receptor blockers.

Movement of the

electrical threshold to more negative values together with prolongation
of the RP may suggest class 3 action (Vaughan Williams, 1980).

Negative

inotropism that can be antagonized by elevation of extracellular calcium
concentration is an effect of class 4 antiarrhythmic drugs
(Fleckenstein, 1977).
McN.2165 (Ethyl-3 ethoxycarbonyl-4 hydroxy-2H-1,
2-benzothiazine-2-acetate-l,l-dioxiode) is an experimental compound
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producing ventricular arrhythmias (Pruss, 1969).

A 5mg/kg dose

administered to anaesthetized dogs, consistently produced conduction
changes such as an increase in the QRS interval and ventricular
fibrillation (Pruss, 1969).

This same compound failed to produce any

ventricular arrhythmias in the in vitro fetal rat heart preparations
(Eyer and Johnson, 1979).

Pronethalol, a beta blocking agent, blocked

the actions of McN.2165 in rats (Eyer and Chan, 1980).

McN.2165 was

chosen to study its effects on the various parameters used as tests for
antiarrhythmic drugs.

McN.2165 showed antiarrhythmic effects in vitro

(Eyer and Johnson, 1979).

A possibility of beta receptor involvement in

its mechanism of action was suggested (Eyer and Chan, 1980).

In fetal

rat hearts in organ culture, the effects of McN.2165 were antagonized by
increasing the calcium ion concentration (Eyer and Johnson, 1979).

The

effects of McN.2165 in the presence of different calcium concentrations
were studied in this work.

Also the effects of the drug were analyzed

in the presence of isoproterenol, a beta agonist.

This work was

undertaken to further investigate the arrhythmogenicity and/or the
antiarrhythmic effects of this compound.

Materials and Methods
Male Hartley strain guinea pigs were purchased from
Ribi-Immuno-Chem, Inc., Hamilton, Montana.

The animals were sacrificed

by a blow on the head and cervical dislocation.

The chest cavity was

cut along the sternum, the heart was removed and placed in a dish
containing cold Tyrode's solution bubbled with 95%

and 5% CO^-
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Tyrode’s solution had the following composition in mM:
0.49, KCl 2.7, CaClg 1.4, NaHCO^ 12, NaH PO

NaCl 137, MgCl^

0.42, and D-glucose 5.6.

The methods were similar to those described by Rashack (1976) and Grout
and co-workers (1962).

The left atrium was dissected away from the

heart and placed in a tissue bath containing oxygenated Tyrode's
solution maintained at 34°C.

The tissue bath was surrounded by a

thermostatically controlled water jacket which kept the temperature
constant throughout the experiment.
driven.

The left atrium was electrically

Electrical stimuli were delivered through a pair of hypodermic

needle electrodes in close proximity to the tissue without a direct
contact.

The electrodes were attached to a Grass stimulator Model SD9.

The duration of stimuli was 2 msec., and the pulse frequency was 2 per
second.

The force of contraction was measured by a Grass Model FT 0.03

force displacement transducer.
level

The signals were amplified through a low

D. C. preamplifier and recorded on a Grass Model 7D polygraph.
The right atrial preparation was placed in a second tissue bath in

the same manner as the left atrium.
beat spontaneously.

The right atrium was allowed to

Resting tension for both atria was 1.0 gm.

The

amplitude was initially adjusted to produce a 10mm pen deflections for
each 0.5 gm of tension.

After the two preparations were set in the

tissue bath, they were allowed to equilibrate for 60 minutes.

The bath

solution was changed after 30 minutes.
The following parameters were measured for the left atrium:
1.

Electrical threshold.

The Grass stimulator Model SD9 was set

in the continuous mode and adjusted to zero volts.

The voltage was

gradually increased until the first continuous train of contractions
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occured.

This voltage was the threshold value.

The voltage was then

increased to twice this threshold value while measuring the rest of the
parameters.
2.

Maximum following frequency.

The twin pulses method was used

to determine the maximum following frequency (Govier, 1965).

Using a

Grass square wave stimulator Model SD9, two pulses of identical voltage
and duration can be obtained.

The time between the onset of the first

and second twin pulses can be varied from 20 to 200 msec.

Starting with

200 msec, delay between pulses, the delay time was gradually reduced
until the second contraction could no longer be observed.
recorded as the maximum following frequency.

This time was

This generally occured

between 90 and 170 msec.
3.

Peak developed tension.

Left atrial contractions displayed on

the polygraph ink-writer were measured as pen deflections in mm, then
converted to force units (gm).

Readings were recorded for both pre-drug

(control) and after each single drug application.

For each dose an

average of 3-4 Pen deflections were calculated to give the final number
used in computing the peak tension.
The right atrial parameters measured were;
1. Spontaneous frequency. The number of contractions in one minute
was taken as the right atrial rate.

Control readings were made

(pre-drug) after 60 minutes of equilibration.

Drug treated readings

were measured after 5 minutes of drug application.

The right atrial

rate was computed for each dose added.
2. Peak developed tension. The force of contraction of the right
atrium was determined in exactly the same manner as the left atrium.
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McN.2165 was dissolved in PEG 200 in an initial concentration of
0.4mM.

Isoproterenol concentrations were prepared in distilled water.

The physiological bath solution (Tyrode's) was also prepared in
distilled water.
Six different doses of McN. 2165 were tested (7.4x10
1.5x10

3x10 ^mM, 4.5x10

7.5x10

1x10 ^mM).

After 60

minutes of equilibration, control readings were taken (all parameters
recorded).

Then doses of McN,2165 were added to the bath solution in an

incremental fashion to give a maximum volume of 1,4 ml.

Five minutes

after addition of each dose all the parameters were recorded.
observations were made for each dose tested.

Ten

In order to minimize the

errors observed with the controls, a ratio (R value) was computed.
R value represents the average of ten observations.

Each

The ratio was

computed by division of drug treated (at each dose) into the control
(pre-drug) readings.

This was done for all the parameters studied.

Calcium ion concentration was varied in Tyrode's solution bathing
the tissue.

Four concentrations were tested (0.7mM, l.OmM, 2.0mM. and

2.7mM).

The normal calcium ion concentration in Tyrode's solution was

1.4mM.

A dose-response curve was constructed in exactly the same manner

as for the normal calcium concentration.

An R value was similarly

computed.
Isoproterenol was employed in concentrations from 10

-7
-3
itiM to 10 mM.

A log dose-response curve was constructed for all the parameters.
concentration of 10

A

-3
mM isoproterenol was considered as the maximum dose

(10 ^mM added to both the left and right atrial preparations produced a
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maximum response).

A concentration of 10 ^mM was tested to show if

there was any surmountable effect. It was found that such effect did
_3
not occur and in fact the 10 mM is the concentration that gave a
maximum response with all the parameters computed.
was calculated.

A ratio (R’ value)

This R' value was computed in a different manner from

the R values mentioned earlier.

The drug treated response at each

single isoproterenol concentration was divided into the maximum response
produced by the 10

-3

mM (Tallarida and Jacob, 1979).

The role of beta receptors in the mode of action of McN.2165 was
investigated.

Log concentrâtion-response curves for isoproterenol in

the presence of McN.2165 were constructed.

High, intermediate and low

-3
-3
-3
mM, 4.5x10 mM and 1.5x10 mM) were used. After
-3
60 minute equilibration, the 10 mM isoproterenol was added to both

dose of McN.2165 (9x10

preparations to obtain a maximum response.
measured.

All the parameters were

The bath solution was then changed twice and the preparations

were allowed to stand for 20 minutes, or until they were back to their
original peak tensions.

McN.2165 was added.

After 8 minutes

isoproterenol concentrations were added starting with the lowest
-7
-3
(10 mM) and proceeding to the highest concentration (10 mM).
Dose-response curves were constructed for all the parameters.

Ten

observations were made for each isoproterenol concentration added to the
bath solution in the presence of the specified dose of McN.2165.
values were calculated.

R*

The drug treated response (each isoproterenol

concentration + the specified McN.2165 dose) was divided into the
-3
maximum response produced by the 10 mM isoproterenol. The response
-3
produced by the 10 mM was considered as unity.
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All data were expressed as the mean ± SEM (standard error of the
mean) for ten observations.

Significant differences were determined by

the student's unpaired t-test.
significant (Osol, 1975).

A p value of 0.05 or less was defined as

The confidence intervals (mean ± t (s//^n )

where n = number of observations) were used to determine significant
differences from unity (Osol, 1975)

(Figs. 8 to 12).

Results
The solvent used for McN.2165 was PEG200.

Dose-response effects of

PEG200 were studied for all the experimental parameters.

PEG200 had no

significant effects on any of the right or left guinea pig atrial
measurements.
McN.2165 produced a dose related increase in threshold response
(Fig. 1).

A prolongation of the maximum following frequency was found

only at the highest dose (1x10

-2

chronotropism was also observed.

mM),

A dose related negative ino- and

A higher concentration of McN.2165 was

required to produce the negative inotropism of the left atrium than that
of the right atrium.
Effects of McN.2165 were tested in the presence of different
calcium concentrations.
electrical threshold.

Figure 2 illustrates the effects of Ca

+2

on the

The control curve represents the effects of

McN.2165 on the threshold measured in normal calcium concentration
(1.4mM in Tyrode's solution).

A dose-related inhibition in the

threshold was observed at three Ca^^ concentrations (2.7mM, l.OmM, and
0.7mM).

The highest Ca

+2

concentration showed the most effective dose

related inhibition of the effects of McN.2165 on the threshold values.
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Fig. 1.

Log concentration-response curves for the effects of M c N . 2165

on various parameters.
frequency,

Electrical threshold,

maximum following

left atrial peak develped tension, ---

right atrial rate,

right atrial peak developed tension.
* Significantly different from the lowest dose of M c N. 2165

(p< 0.05).

R = ratio of drug treated/control responses.
Each point represents the mean of ten observations.

Overlapping SEM

bars have been omitted from the graph.
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Fig. 2.

Log concentration-response curves for the effects of M c N . 2165

in the presence of various calcium ion concentrations.

Measurement of

the electrical threshold of the left atrium.
2.0mM,
*

2.7mM,

l.OmM,

0.7mM,

1.4mM.

Significantly different from the lowest dose of M cN .2165.

(p < 0.05)

Significantly different from the corresponding dose of the control
(1. 4mM) , p < 0. 05.
R = ratio of drug treated/control responses.
Each point represents the mean of ten observations

R eproduced with permission of the copyright owner. Further reproduction prohibited without permission.

24

2.4-1
2.322

-

2.0 19 1.8

R

-

1.7.6 -

.51.41.312-

,0-

-314 -2.84 -2.53-2.36-2.14 -184

LOG CONCENTRATION (mM)

R eproduced with permission of the copyright owner. Further reproduction prohibited without permission.

25

High and low calcium concentrations, 2.7mM and litiM respectively,
inhibited the prolongation of the maximum following frequency observed
in the presence of McN.2165 (Pig. 3).
highest dose of McN.2165 (1x10

-2

These results were found at the

mM).

The highest calcium concentration, 2.7mM, resulted in a pronounced
dose-related inhibition of the negative chronotropic effect produced by
McN.2165 (Fig. 4).
of inhibition.

Also calcium concentration of ImM showed some degree

This was seen at moderately high doses of McN.2165

(4.5xl0“^mM, 7.5xlO~^mM).
Effects of various Ca

+2

concentrations on the left atrial peak

developed tension are presented in Figure 5-

The lowest calcium

concentration (0.7mM) enhanced the effect of McN.2165.
the highest dose (1x10

-2
mM).

This was seen at

On the other hand, calcium concentration

of 2.7mM inhibited the effect of McN.2165 on this parameter.
found at only one dose of the drug (4.5x10

-3

This was

mM).

Elevating the calcium concentration inhibited the negative
inotropism of McN.2165 on the right atrium (Fig. 6).

The highest

calcium concentration (2.7mM) prevented the negative inotropism of
McN.2165 at all doses.

On the other hand calcium concentration of 2mM

inhibited this effect only at higher doses (4.5x10 ^mM, 1x10 ^mM).
A log concentration-response curve was constructed for
isoproterenol (Fig. 7).

A maximum response was obtained with 10

Isoproterenol produced positive ino- and chronotropic effects-

-3
mM.
In

addition, shortening of the maximum following frequency was also seen.
No significant change (p < 0.05) was observed on threshold values.

R eproduced with permission of the copyright owner. Further reproduction prohibited without permission.

26

Fig. 3.

Log concentration-response curves for the effects of McN.2165

in the presence of various calcium ion concentrations.

Measurement of

the maximum following frequency.
2.0mM,

2.7mM, ---

l.OmM,

0.7mM,

1.4mM.

★ Significantly different from the lowest dose of M en . 2165

(p < 0.05).

Significantly different from the corresponding dose of the control
(1.4mM) p' <0.05) .
R = ratio of drug treated/control responses.
mean of ten observations.

Each point represents the

Overlapping SEM bars have been omitted from

the graph.
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Fig. 4.

Log concentration-response curves for the effects of McN.2165

in the presence of various calcium ion concentrations.

Measurement of

the right atrial rate.
2.0mM,
*

2 . 7 m M , ---- l.OniM,

0.7mM,

1.4mM.

Significantly different from the lowest dose of M c N . 2165

(p <0.05).

Significantly different from the corresponding dose of the control
(1.4mM) p < 0.05.
R = ratio of drug treated/control responses.
mean of ten observations.

Each point represents the

Overlapping SEM bars have been omitted from

the graph.
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Fig. 5.

Log concentration-response curves for the effects of McN.2165

in the presence of various calcium ion concentrations.

Measurement of

the left atrial peak developed tension.
2.0mM,

2.7mM, --- l.OmM,

0.7mM,

1.4mM.

* Significantly different from the lowest dose of McN.2165, p < 0.05.
Significantly different from the corresponding dose of the control
(1.4mM) p < 0.05.
R = ratio of drug treated/control responses.
mean of ten observations.

Each point represents the

Overlapping SEM bars have been omitted from

the graph.
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Pig. 6.

Log concentration-response curves for the effects of McN.2165

in the presence of various calcium ion concentrations-

Measurement of

the right atrial peak developed tension.
2.OmMf
*

2-7mM, -—

l.OmM,

0.7mM,

1.4mM.

Significantly different from the lowest dose of McN2165
Significantly different from the control

R = ratio of drug treated/control responses.
mean of ten observations.

(p <0-05).

(1.4mM) p <0.05.
Each point represents the

Overlapping SEM bars have been omitted from

the graph.
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Fig. 7.

Log concentration-response curves for isoproterenol on various

parameters.
Maximum following frequency,
rate,

electrical threshold,

right atrial peak developed tension,

right atrial

left atrial peak

developed tension.
* Significantly different from the lowest dose of isoproterenol
(p < 0.05) .
R = ratio of drug treated/10

-3

mM response

Each point represents the mean of ten observations.

Overlapping SEM

bars have been omitted from the graph.
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McN.2165 at a concentration of 4.5x10 ^itiM increased the threshold
at almost all isoproterenol concentrations (10 ^mM - 10 ^mM) (Fig. 8).
Another significant increase in the threshold was found at 1.5xlO~^mM
McN.2165.

This was observed only at higher concentrations of

isoproterenol.
Effects of isoproterenol on the maximum following frequency in the
presence of McN.2165 are illustrated in Figure 9.

At low concentrations

of isoproterenol there was a significant inhibition of this parameter.
This was observed with the lowest dose of McN.2165 (1.5x10

—3
mM).

Isoproterenol by itself (control curve) shortened this parameter at high
concentrations (10 ^mM, 10 ^raM) (Fig. 7).

However, McN.2165 did not

affect this parameter at these concentrations.
Figure 10 represents the effects of isoproterenol on the left
atrial peak developed tension in the presence of McN.2165.

The positive

inotropism of isoproterenol was inhibited in a dose related fashion in
-3
the presence of the highest dose of McN.2165 (9x10 mM).

The inhibition

was insurmountable at all doses of McN.2165.
The positive chronotropism of isoproterenol was depressed in the
presence of McN.2165 (Fig. 11).

A significant depression was observed

”4
—3
at higher isoproterenol concentrations (10 mM, 10 mM).

This

depression was insurmountable.
McN.2165 produced a dose-related inhibition of the positive
inotropic effect of isoproterenol on the right atrium (Fig. 12).

The

most effective inhibition was observed with the lowest dose of McN.2165
(1.5x10 ^mM).

This was seen in all isoproterenol concentrations.

inhibition of this parameter was also insurmountable.
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Fig. 8.

Log concentration-response curves for isoproterenol in the

presence of three different concentrations of M cN.2165.
Measurement of the electrical threshold.
4.5x10
*

-3

mM,

9x10

-3

mM,

1.5x10

-3

mM,

--- control

Significantly different from the corresponding dose of the control

(p < 0.05) .
R' = ratio of drug treated/10

-3

mM responses

Each point represents the mean of ten observations.

Overlapping SEM

bars have been omitted from the g r a p h .

R eproduced with permission of the copyright owner. Further reproduction prohibited without permission.

38

1.5-

1.3-

R' i2-

1.1'

1.0-

0.9-

~r
-7

— r
-6

T
-5

—r
-4

LOG CONCENTRATION (mM)

R eproduced with permission of the copyright owner. Further reproduction prohibited without permission.

39

Fig. 9.

Log concentration-response curves for isoproterenol in the

presence of three different concentrations of M c N . 2165.
Measurement of the maximum following frequency.
4.5x10

-3

mM,

9x10

-3

mM,

1.5x10

-3

mM,

--- control.

* Significantly different from the lowest dose of isoproterenol
(p< 0.05).
Significantly different from the corresponding dose of the control
(p < 0.05) .
R' = ratio of drug treated/10

-3

laM response

Each point represents the mean of ten observations.

Overlapping SEM

bars have been omitted from the graph.
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Fig. 10.

Log concentration-response curves for isoproterenol in the

presence of three different concentrations of M cN .2165.
Measurement of the left atrial peak developed tension.
4.5x10

-3

mM,

9x10

-3

mM,

1.5x10

-3

mM,

--- control

* Significantly different from the lowest dose of isoproterenol
(p < 0-05) .
Significantly different from the corresponding dose of the control
(p < 0.05) .
R' = ratio of drug treated/10 ^mM responses
Each point represents the mean of ten observations.

Overlapping SEM

bars have been omitted from the graph.
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Fig.

11.

Log concentration-response curves for isoproterenol in the

presence of three different concentrations of McN.2165.

Measurement of

the right atrial rate.
4.5x10

3
mM,

9x10

— 3
mM,

“3
1.5x10 mM,

--- control.

* Significantly different from the lowest dose of isoproterenol
(p <0.05).
Significantly different from the corresponding dose of the control
(p < 0. 05) .
R* = ratio of drug treated/10

-3

m M responses

Each point represents the mean of ten observations.

Overlapping SEM

bars have been omitted from the graph.
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Fig. 12.

Log concentration-response curves for isoproterenol in the

presence of three different concentrations of McN.2155.

Measurement of

the right atrial peak developed tension.
4.5x10

9x10 ^mM,

1.5x10 ^mM,

--- control

* Significantly different from the lowest dose of isoproterenol
(p < 0. 05)
Significantly different from the corresponding dose of the control
(p < 0.05) R' = ratio of drug treated/10

-3

mM responses

Each point represents the mean of ten observations-

Overlapping SEM

bars have been omitted from the graph.
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Discussion
The etiology of cardiac arrhythmias is obscure.

Although many

hypotheses have been implied for their mechanism of action, there is
still much more to be discovered.

When a new antiarrhythmic drug is

introduced it is naturally compared with other drugs already in use to
explain and understand its mode of action.

Currently available

antiarrhythmic drugs fall into one or more of four classes of action.
Reasons were given, both practical and theoretical, for believing that
those four classes could provide a rational explanation for clinical
efficacy (Vaughan Williams, 1980).

In this study we investigated the

effects of McN.2165 on various parameters used as screening tests for
antiarrhythmic drugs.
This compound produced ventricular arrhythmias in the form of
multifocal ectopic beats, ventricular tachycardia and ventricular
fibrillation in intact dog (Pruss, 1969).

On the other hand, McN.2165

showed negative chronotropism in fetal rat hearts (Eyer and Johnson,
1979).

In the current study McN.2165 clearly demonstrated

antiarrhythmic properties (Figs. 1-12).

This compound at moderate and

high doses produced negative ino- and chronotropic effects.
increase in the electrical threshold was also seen.

A marked

The latter effect

indicated a stronger stimulus was required to elicit a propagated AP.
Prolongation of the maximum following frequency was found only at the
highest dose.

A uniform prolongation of APD ought, in theory, to be

antiarrhythmic factor (Green, 1975).

Nevertheless, the existence of

fiber bundles with short and long APD is highly arrhythmogenic.
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latter statement is supported by the high incidence of arrhythmias and
sudden death in the prolonged Q-T syndrome (Vaughan Williams, 1980).
From the few studies done on McN.2165 it was suggested that its
mechanism of action may involve beta receptors of the heart and/or a
calcium effect (Eyer and Johnson, 1979; Eyer and Chan, 1980).
It was found that calcium plays a role in effects of McN.2165.
Singer and coworkers (1969) found that decreasing the extracellular
calcium, [Ca]

+2

, shifted the threshold potential toward

A high (Ca]

values.

+2

causes the opposite results.

more negative

When testing the

effects of McN.2165 in various calcium concentrations, it was found that
both high and low [Ca]

+2

shifted the threshold to low values.
+2

reduction in threshold observed at low [Ca]^
to the literature (Singer et
+2
with high [Ca]^ .

, 1969) .

The

can be expected according

The same reduction was found

This finding suggested that McN.2165 might require

an optimal calcium concentration to exert its effects.

This is
+2

supported by the fact that a moderate increase in [Ca]^

did not show

any significant change in the threshold compared to the control
(Fig. 2).
Shortening of the maximum following frequency in high and low
+2

[Ca]^

further supported the role of calcium in the effects of McN.2165

(Fig. 3).

Elevating the [Ca]

+2

will increase both the depolarizing rate

and the potassium conductance (Langer, 1973; Miller, 1976).
effect will enhance repolarization and shorten the APD.
+2

hand, lowering the [Ca]^
estimation of the RP.

The last

On the other

will prolong the APD, which is usually an

Both hypo- and hypercalcemia lead to arrhythmias
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(Katz, 1977).

It was shown that McN.2165 prolonged the RP in normal

calcium concentration, at least in high doses (Fig. 1).
+2

Low [Ca]^

will decrease the force of contraction because it is the

major ion involved in the excitation-contraction coupling mechanism
(Nay1er, 1975).

High [ C a ] i n h i b i t e d the negative inotropism produced

by McN.2165 in both the left and right atrial preparations.
+2

other hand, at lowest [Ca]^

On the

an enhancement of the negative inotropism

of the left atrium was observed at the highest dose of McN.2165
(Fig. 5).

This might be expected due to the fact that low extracellular

calcium by itself will decrease the force of contraction (Nay1er, 1975).
The net inhibition found in the right atrium was much more pronounced
than the left upon varying the calcium concentration.

This may be

attributed to the differences existing between the spontaneous intrinsic
rhythmicity of the right atrium and the electrical pacing of the left
atrium (Daniel and Paton, 1975).

It is well known that there is an

interaction between force and rate (Schwartz, 1971).

The right atrial

preparations were beating at an average of 180 beats/min.

On the other

hand, the left atria were paced at 120 beats/min.
Elevation of [Ca]

+2

protected against the negative chronotropic

effect of McN.2165 (Fig. 4).
Increasing [Ca]

The inhibition was surmountable.

+2

increases the slow inward current, i
, which will
°
®i
shift the plateau to greater positivity. There is strong evidence that
this current underlies phase zero in the SA node (Brown and Difrancisco,
1980).

+2

The increase in [Ca]^

will shorten the APD and enhance

repolarization by increasing the

conductance (Reuter, 1967; Beeler
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and Reuter, 1970).
increased.
effects.

Consequently, the number of APs per unit of time is

This will increase the rate.

Low [Ca]

causes the opposite

Isoproterenol alone did not show any significant change in the

electrical threshold.

McN,2155 by itself increased this parameter.

Therefore, McN.2165 with or without isoproterenol increased the
electrical threshold.

This suggested that there was no interaction

between these two drugs, at least in regard to this parameter.
Catecholamines shorten the APD, and the RP is correspondingly
decreased (Goodman and Gilman, 1980).

A marked increase or decrease in

the APD could lead to arrhythmias (Vaughan Williams, 1980).

McN.2165

was unable to prevent the shortening of the maximum following frequency
produced at high concentrations of isoproterenol (Fig. 9).

On the other

-7
-6
hand, at low concentrations of isoproterenol (10 mM, 10 mM), McN.2165
(at low dose) shifted this parameter to higher values.

This result may

be spurious because isoproterenol itself did not change this parameter.
Catecholamines produce a positive inotropism through beta receptor
interactions with the cyclic nucleotide system.

This interaction

elevates intracellular levels of cAMP which triggers a series of
physiochemical reactions.
(Nayler, 1975).

Calcium plays a major role in these reactions

Propranolol, a beta antagonist, was found to reverse

this effect and lower intracellular levels of cAMP through beta receptor
blockade (Malkinson, 1975).

It is suggested that McN.2165 may increase

intracellular cAMP levels (Eyer and Chan, 1980).
McN.2165 exerted a negative inotropism.

In this laboratory

The negative inotropism of the

right atrium was much more pronounced than that of the left atrium.
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This was found with all isoproterenol concentrations when the dose of
McN.2165 was the lowest (1.5x10 ^mM).

On the other hand, the negative

inotropism of the left atrium was produced by the highest dose of
-3
McN.2165 (9x10 mM). From figures 10 and 12 it can be seen that the
curves were shifted to the right.

The inhibition of isoproterenol

effects was non-competitive as increasing the concentration did not
bring back the effect to the initial standard level.

This suggests that

McN.2165 might have acted through non-competitive mechanism to depress
the inotropic effect.

Depression of isoproterenol positive

chronotropism by McN.2165 was observed at high concentrations (Fig. 11).
Depression of automatic!ty is a property of most of the antiarrhythmic
drugs (Rosen and Hoffman, 1975; 1973; Singer et a_l., 1967; Graca and
Zwieten, 1971; Goodman and Gilman, 1980).

This blockade of the

isoproterenol effect by McN.2165 was insurmountable.
From the results obtained in this study, it was found that McN.2165
showed antiarrhythmic actions based on its negative ino- and
chronotropism, its ability to increase the electrical threshold, and its
prolongation of the maximum following frequency.
How McN,2165 exerts its antiarrhythmic actions is unclear.

The

negative inotropism and the increase in the threshold are
characteristically produced by class 1 antiarrhythmic agents, via
restriction of the fast inward sodium current.

Amiodarone produces

negative inotropism through both class 2 antisympathetic actions (acute
effect) and class 3 prolongation of the RP (chronic effect)
Williams, 1980).

(Vaughan

Class 4 antiarrhythmic drugs reduce the force of

R eproduced with permission of the copyright owner. Further reproduction prohibited without permission.

52

contraction by blocking the slow inward calcium current, thus reducing
the intracellular calcium available for the contractile process.

Class

2 agents produce negative ino- and chronotropism via beta receptor
blockade.
McN.2165 inhibited insurmountably the positive ino- and
chronotropic effects of isoproterenol.

In addition, isoproterenol was

unable to overcome the increase in the electrical threshold observed
with McN.2165 (Fig- 8).

McN.2165 could not modify the shortening of the

maximum following frequency produced by isoproterenol (Fig. 9).

From

these results it is improbable that McN.2165 exerts its cardiac effects
via a competitive interaction with beta^ receptors.Calcium protected
against most of the effects of McN.2165 (elevation of the threshold,
prolongation of the maximum following frequency, negative ino- and
chronotropism of the right atrium). These data support an interaction
between calcium and McN.2165.

This interaction would also be expected

from class 4 anti-arrhythmic drugs (Landmark and Refsum, 1977).
It is well known that many antiarrhythmic drugs such as DPH,
lidocaine, and quinidine are arrhythmogenic in toxic doses (Goodman and
Gilman, 1980).
1969).

In vivo, McN.2165 is an arrhythmogenic agent (Pruss,

Both prolongation and shortening of the RP can be arrhythmogenic

(Katz, 1977).

A uniform prolongation of the RP is an antiarrhythmic

action (Vaughan Williams, 1980).
maximum following frequency.
nonuniform.
experiments.

In vitro McN.2165 prolonged the

This can be arrhythmogenic if it is

The latter activity could not be detected in these
However, this effect was minimal, as only the highest

concentration showed a significant change.
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In conclusion McN.2165 demonstrates antiarrhythmic effects in
vitro.

Pharmacologically, its action may involve one or more of the

mechanisms associated with typical antiarrhythmic drugs (classes 1, 3,
or 4).

Some role for a class 4 type action of McN.2165 is suggested.

Class 2 beta^ receptor blockade is excluded.
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